How a Network Came Together to Manage a Large Research Program During the Pandemic

Authors

  • Tamara Friedman Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA
  • Elli G. Paleoudis Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA
  • Avery Freed Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA
  • Susan Adler Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA
  • Cheryl Fittizzi Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA
  • Ihor Sawczuk Office of Research Administration, Hackensack Meridian Health, 40 Prospect St, Hackensack, NJ 07601, USA; Hackensack Meridian Health School of Medicine, 340 Kingsland St Ste 123, Nutley, NJ 07110, USA

DOI:

https://doi.org/10.17140/CTPOJ-3-114

Keywords:

Research administration, COVID-19, Network

Abstract

Hackensack Meridian Health, a large New Jersey network comprised of 17 hospitals, a medical school, and 200 ambulatory care
centers, executes a large research program with approximately 1000 active human subjects studies. With the arrival of the coronavirus
disease-2019 (COVID-19) pandemic, the Office of Research Administration was confronted with a series of challenges.
These included minimizing face-to-face contact among research participants and staff, allocating limited resources to handle
the influx of COVID-19 related proposals, providing human subjects protection training to the physicians and staff who were
needed to run the clinical trials, adjusting bio-repository activities to meet the increased demand for samples, and disseminating
all of the new regulatory and operational information to the thousands of researchers in the network. The network’s success in
modifying its research program quickly and effectively to adapt to the changing landscape can be attributed, in large part, to the
centralized nature of the research administration.

References

Department of Health. New Jersey COVID-19 Dashboard. state.nj.us Web site. https://www.state.nj.us/health/cd/topics/ covid2019_dashboard.shtml. Accessed June 10, 2020. Commentary | Volume 3 | Number 1 | Clin Trial Pract Open J. 2020; 3(1): 20-22. doi: 10.17140/CTPOJ-3-114

U.S. Food and Drug Administration (FDA) COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stake-holders.fda.gov Web site. https://www.fda.gov/emergency-pre-paredness-and-response/coronavirus-disease-2019-covid-19/ covid-19-related-guidance-documents-industry-fda-staff-and-oth-er-stakeholders. Accessed June 10, 2020.

DocuSign. No matter what, no matter where. docusign Web site. https://www.docusign.com/. Accessed June 10, 2020.

Cocanour CS. Informed consent-It’s more than a signature on a piece of paper. Am J Surg. 2017; 214(6): 993-997. doi: 10.1016/j. Submit your article to this journal | https://openventio.org/submit-manuscript/ Commentary | Volume 3 | Number 1 | Friedman T et al amjsurg.2017.09.015

National Institutes of Health, All of Us Research Program launches COVID-19 research initiatives. nih.gov Web site. https:// www.nih.gov/news-events/news-releases/all-us-research-pro-gram-launches-covid-19-research-initiatives. Accessed June 10, 2020.

Thornton, K. An Analysis ofAcademic Research AdministrationCen-tral Office Structures. [master’s thesis]. Baltimore, MD, USA: Johns Hopkins University; 2017.

Downloads

Published

2020-07-27

How to Cite

Tamara Friedman, Elli G. Paleoudis, Avery Freed, Susan Adler, Cheryl Fittizzi, & Ihor Sawczuk. (2020). How a Network Came Together to Manage a Large Research Program During the Pandemic. Clinical Trials and Practice – Open Journal, 3(1), 20–22. https://doi.org/10.17140/CTPOJ-3-114

Issue

Vol. 3 No. 1 (2020): Volume 3 Issue 1 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Clinical Trials and Practice – Open Journal (CTP) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.